在线自适应磁共振引导放疗在胰腺癌中的应用:现状、要点与陷阱
本文综述在线自适应磁共振引导放疗(MRgRT)在胰腺癌治疗中的现状、要点与陷阱。胰腺癌放疗受周围高放射敏感危及器官毒性限制,且存在显著分次间和分次内靶区变异。MRgRT 利用高软组织对比准确识别靶区、 cine MRI 监测位置,并可在患者仍在治疗床时在线自适应调整剂量分布。
要点
- MRgRT 高软组织对比有助于准确识别胰腺癌放疗靶区。
- cine MRI 可实时监测分次内肿瘤与危及器官位置变化。
- 在线自适应计划可在患者离床前调整剂量分布,应对变异。
核心结论
- 在线自适应 MRgRT 可控制胰腺癌放疗中多数不确定性来源,但存在主要陷阱与创新机会。
研究设计与样本
- 本文为综述,旨在呈现并讨论在线自适应 MRgRT 在胰腺癌治疗中的现状、主要陷阱与创新机会。
主要发现
- 近年不同研究证明大分割放疗改善局部晚期不可切除胰腺癌患者的总生存。
- 胰腺癌周围高放射敏感危及器官的毒性限制靶区处方剂量。
- 治疗体积存在显著分次间和分次内变异,主要与空腔器官和呼吸周期有关。
- MRgRT 利用 MRI 高软组织对比准确识别放疗体积,并用高时间 cine MRI 监测分次内肿瘤与危及器官位置。
- 在线自适应可在患者仍在治疗床时改变剂量分布,成功应对多数变异来源。
临床怎么用
- 临床可利用 MRgRT 的高软组织对比和 cine MRI 监测来识别靶区与分次内位置变化。
- 在线自适应计划可在患者仍在治疗床时调整剂量分布以应对分次间和分次内变异。
局限性
- 本文为综述,未报告具体研究样本量、效应量或统计检验结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Different studies have proved in recent years that hypofractionated radiotherapy (RT) improves overall survival of patients affected by locally advanced, unresectable, pancreatic cancer. The clinical management of these patients generally leads to poor results and is considered very challenging, due to different factors, heavily influencing treatment delivery and its outcomes. Firstly, the dose prescribed to the target is limited by the toxicity that the highly radio-sensitive organs at risk (OARs) surrounding the disease can develop. Treatment delivery is also complicated by the significant inter-fractional and intra-fractional variability of therapy volumes, mainly related to the presence of hollow organs and to the breathing cycle. The recent introduction of magnetic resonance guided radiotherapy (MRgRT) systems leads to the opportunity to control most of the aforementioned sources of uncertainty influencing RT treatment workflow in pancreatic cancer. MRgRT offers the possibility to accurately identify radiotherapy volumes, thanks to the high soft-tissue contrast provided by the Magnetic Resonance imaging (MRI), and to monitor the tumour and OARs positions during the treatment fraction using a high-temporal cine MRI. However, the main advantage offered by the MRgRT is the possibility to online adapt the RT treatment plan, changing the dose distribution while the patient is still on couch and successfully addressing most of the sources of variability. SHORT CONCLUSION: Aim of this study is to present and discuss the state of the art, the main pitfalls and the innovative opportunities offered by online adaptive MRgRT in pancreatic cancer treatment.
引用
- Boldrini L, Cusumano D, Cellini F, et al. Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls. Radiat Oncol. 2019. PMID: 31036034. doi:10.1186/s13014-019-1275-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。